TD Cowen maintains Buy rating on Visteon, $131 price target

TD Cowen maintained a Buy rating on Visteon with a $131 price target, suggesting a 60.3% upside from the Oct 22 close. The firm cited strong revenue growth prospects and undervaluation at 4x EV/EBITDA, supported by a robust pipeline and net cash balance.

Original reporting
Published Oct 23, 2026, 1:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 1:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
TD Cowen maintains Buy rating on Visteon, $131 price target — source image
Decision brief

The 30-second read

Med
01

Why it matters

The upgrade could trigger short‑term buying and raise the stock toward the $131 target.

02

Market read

Analyst rating change with a higher price target provides a fresh catalyst for Visteon.

03

What to watch

Potential supply-chain constraints and macro headwinds could limit upside.

Relevance 7/10Novelty 6/10Timing: today

Background

TD Cowen's note follows Visteon's recent earnings and outlines a multi‑year growth outlook.

Market effects

Positive outlook for automotive electronics may lift peers in the sector.

Limited to US auto parts market.

Minor, confined to Visteon and related suppliers.

Counterpoint

The target may be overly optimistic if revenue growth stalls.

Key entities

  • TD Cowen

    Equity research firm issuing the rating.

  • Visteon

    Automotive electronics supplier.

Related articles

$VCMed

Visteon stock falls as CFO Jerome Rouquet set to depart

Visteon Corp (VC) shares fell 4% after announcing CFO Jerome Rouquet will depart by November 30, 2026. Colleen Myers, current VP and Chief Accounting Officer, will serve as interim CFO. The company is searching for a permanent successor. Rouquet has been with Visteon for six years. CEO Sachin Lawande expressed confidence in Myers' leadership during the transition.

$VCMed

Visteon CFO Jerome Rouquet to depart, Myers named interim

Visteon (VC) announced CFO Jerome Rouquet will depart by November 30, 2026. Colleen Myers, current VP and Chief Accounting Officer, will serve as interim CFO. The company has started a search for a permanent replacement. Rouquet joined Visteon six years ago, while Myers has been with the company since 2015. VC is an automotive technology supplier operating in 17 countries.

$VCMed

Visteon Announces Departure of Chief Financial Officer

Visteon Corporation (NASDAQ: VC) announced that Jerome Rouquet, its CFO, will leave the company on November 30, 2026. Colleen Myers, Vice President and Chief Accounting Officer, will serve as interim CFO. The company has started a search for a permanent replacement. Rouquet will assist in the transition until his departure.

Med

Visteon Corporation Q3 2026 Earnings Call Summary

Visteon Corporation reported Q3 2026 earnings, highlighting 10 percentage points of market outperformance despite a 5% decline in vehicle production. The company addressed $77 million in warranty charges and managed inflation in PCBs. For 2027, Visteon anticipates $500 million in incremental costs and aims to maintain EBITDA targets through customer recoveries. China sales are expected to grow in Q4 2026, driven by high-performance compute launches.

Med

Visteon (VC) Q3 2026 Earnings Call Transcript

Visteon (VC) reported Q3 2026 earnings, highlighting a $200M share repurchase and sales growth despite market challenges. Sales grew in Americas, Europe, and Asia (excluding China), with China sales expected to recover in Q4. The company launched 21 new products, including high-value cockpit technologies, and secured $1B in new business bookings, targeting $6B for the year. Strategic wins include programs with Toyota, Maruti Suzuki, and Tata Motors.